Dapagliflozin API

Holiness Pharmaceutical is a trusted and leading manufacturer and Pharmaceutical API exporter of Dapagliflozin API, supplying high-quality anti-diabetic APIs in IP, BP, and USP grades to pharmaceutical companies across 40+ international markets. Dapagliflozin is a next-generation SGLT2 inhibitor widely used in the management of type-2 diabetes mellitus, heart failure, and chronic kidney disease, making us a reliable Dapagliflozin bulk API supplier from India.

Globally, Holiness Pharmaceutical is recognized among the most reputable Dapagliflozin API manufacturers, offering high assay purity, strict control of related substances, excellent crystalline consistency, and strong stability profiles suitable for oral solid dosage formulations. Our expertise in advanced metabolic and cardio-renal molecules positions us as a dependable Pharmaceutical API exporter.

Our advanced anti-diabetic API manufacturing facilities operate in strict compliance with international pharmaceutical regulatory standards including:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP guidelines,
ensuring validated synthesis routes, robust impurity control, particle size consistency, and pharmacopeial compliance for Dapagliflozin API.

We export Dapagliflozin API and other anti-diabetic APIs from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting formulation manufacturers producing oral antidiabetic therapies, fixed-dose combinations, and cardio-renal protection medicines. Holiness Pharmaceutical is widely trusted as a bulk Dapagliflozin API supplier.

Holiness Pharmaceutical is one of the leading producers of APIs (Active Pharmaceutical Ingredients) and Intermediates, delivering GMP-compliant manufacturing systems, consistent batch quality, and globally accepted regulatory documentation as a certified Pharmaceutical API exporter specializing in metabolic and chronic-care APIs.

Holiness Pharmaceutical Ltd manages the complete lifecycle of API development — including R&D innovation, complex molecule synthesis, commercial-scale manufacturing, HPAPI capabilities, and worldwide distribution of APIs and intermediates.

Recognized globally for quality, regulatory reliability, and supply consistency, Holiness Pharmaceutical stands among the top API manufacturers in India, supported by advanced QA/QC laboratories, modern production infrastructure, and a rapidly expanding international supply network as a leading bulk API supplier.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.